Rovaldi Christopher
CIK 0001706040
Chief Operating Officer
Filings
6
Latest Feb 19, 2025
Issuers covered
1
Showing
6 of 6
Page 1
Track record
6 of 6 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 6 | 100% | +10.2% | +6.5% | +28.3% | +6.5% |
| 90 days | 6 | 100% | +54.0% | +53.5% | +56.5% | +53.5% |
| 180 days | 6 | 100% | +38.7% | +38.4% | +40.5% | +38.4% |
| 365 days | 6 | 100% | +29.5% | +27.5% | +39.5% | +27.5% |
Issuers
Companies where Rovaldi Christopher has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| KROS | Keros Therapeutics, Inc. | 6 | Feb 19, 2025 |
All filings
6 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|